Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2010
Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strainHector Bonilla, Michael D Huband, Joan Seidel, et al.
Antimicrobial Agents and Chemotherapy|April 23, 2008
In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin AGregory G Stone, Dennis Girard, Steve Finegan, et al.
Diagnostic Microbiology and Infectious Disease|September 20, 2020
In vitro activity of KHP-3757 (a novel LpxC inhibitor) and comparator agents against recent and molecularly characterized Pseudomonas aeruginosa isolates from a global surveillance program (2017-2018)Michael D Huband, Jill M Lindley, Rodrigo E Mendes, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolatesThomas V Magee, Seungil Han, Sandra P McCurdy, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeaeRichard A Alm, Sushmita D Lahiri, Amy Kutschke, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2007
A distal methyl substituent attenuates mitochondrial protein synthesis inhibition in oxazolidinone antibacterialsAdam R Renslo, Andy Atuegbu, Prudencio Herradura, et al.
Antimicrobial Agents and Chemotherapy|January 31, 2007
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groupsMichael D Huband, Michael A Cohen, Margaret Zurack, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex IsolatesMichael D Huband, Rodrigo E Mendes, Michael A Pfaller, et al.
Antimicrobial Agents and Chemotherapy|January 7, 2015
Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumanniiWilliam F Penwell, Adam B Shapiro, Robert A Giacobbe, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2023
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzaeSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Pageof 9